Global Oncolytic Virus Therapy Market Research Report 2024, Forecast to 2032
Report Overview
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
The global Oncolytic Virus Therapy market size was estimated at USD 6 million in 2023 and is projected to reach USD 44.38 million by 2032, exhibiting a CAGR of 24.90% during the forecast period.
North America Oncolytic Virus Therapy market size was estimated at USD 2.30 million in 2023, at a CAGR of 21.34% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Oncolytic Virus Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oncolytic Virus Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oncolytic Virus Therapy market in any manner.
Global Oncolytic Virus Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys
Market Segmentation (by Type)
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses
Market Segmentation (by Application)
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncolytic Virus Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Oncolytic Virus Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
The global Oncolytic Virus Therapy market size was estimated at USD 6 million in 2023 and is projected to reach USD 44.38 million by 2032, exhibiting a CAGR of 24.90% during the forecast period.
North America Oncolytic Virus Therapy market size was estimated at USD 2.30 million in 2023, at a CAGR of 21.34% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Oncolytic Virus Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oncolytic Virus Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oncolytic Virus Therapy market in any manner.
Global Oncolytic Virus Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys
Market Segmentation (by Type)
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses
Market Segmentation (by Application)
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Oncolytic Virus Therapy Market
- Overview of the regional outlook of the Oncolytic Virus Therapy Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncolytic Virus Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Oncolytic Virus Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Oncolytic Virus Therapy
1.2 Key Market Segments
1.2.1 Oncolytic Virus Therapy Segment by Type
1.2.2 Oncolytic Virus Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONCOLYTIC VIRUS THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oncolytic Virus Therapy Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Oncolytic Virus Therapy Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONCOLYTIC VIRUS THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Oncolytic Virus Therapy Sales by Manufacturers (2019-2024)
3.2 Global Oncolytic Virus Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oncolytic Virus Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oncolytic Virus Therapy Sales Sites, Area Served, Product Type
3.6 Oncolytic Virus Therapy Market Competitive Situation and Trends
3.6.1 Oncolytic Virus Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oncolytic Virus Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ONCOLYTIC VIRUS THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Oncolytic Virus Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONCOLYTIC VIRUS THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ONCOLYTIC VIRUS THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncolytic Virus Therapy Sales Market Share by Type (2019-2024)
6.3 Global Oncolytic Virus Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Oncolytic Virus Therapy Price by Type (2019-2024)
7 ONCOLYTIC VIRUS THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncolytic Virus Therapy Market Sales by Application (2019-2024)
7.3 Global Oncolytic Virus Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Oncolytic Virus Therapy Sales Growth Rate by Application (2019-2024)
8 ONCOLYTIC VIRUS THERAPY MARKET CONSUMPTION BY REGION
8.1 Global Oncolytic Virus Therapy Sales by Region
8.1.1 Global Oncolytic Virus Therapy Sales by Region
8.1.2 Global Oncolytic Virus Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Oncolytic Virus Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oncolytic Virus Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oncolytic Virus Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oncolytic Virus Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oncolytic Virus Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 ONCOLYTIC VIRUS THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Oncolytic Virus Therapy by Region (2019-2024)
9.2 Global Oncolytic Virus Therapy Revenue Market Share by Region (2019-2024)
9.3 Global Oncolytic Virus Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Oncolytic Virus Therapy Production
9.4.1 North America Oncolytic Virus Therapy Production Growth Rate (2019-2024)
9.4.2 North America Oncolytic Virus Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Oncolytic Virus Therapy Production
9.5.1 Europe Oncolytic Virus Therapy Production Growth Rate (2019-2024)
9.5.2 Europe Oncolytic Virus Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Oncolytic Virus Therapy Production (2019-2024)
9.6.1 Japan Oncolytic Virus Therapy Production Growth Rate (2019-2024)
9.6.2 Japan Oncolytic Virus Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Oncolytic Virus Therapy Production (2019-2024)
9.7.1 China Oncolytic Virus Therapy Production Growth Rate (2019-2024)
9.7.2 China Oncolytic Virus Therapy Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Amgen
10.1.1 Amgen Oncolytic Virus Therapy Basic Information
10.1.2 Amgen Oncolytic Virus Therapy Product Overview
10.1.3 Amgen Oncolytic Virus Therapy Product Market Performance
10.1.4 Amgen Business Overview
10.1.5 Amgen Oncolytic Virus Therapy SWOT Analysis
10.1.6 Amgen Recent Developments
10.2 Oncolytics Biotech
10.2.1 Oncolytics Biotech Oncolytic Virus Therapy Basic Information
10.2.2 Oncolytics Biotech Oncolytic Virus Therapy Product Overview
10.2.3 Oncolytics Biotech Oncolytic Virus Therapy Product Market Performance
10.2.4 Oncolytics Biotech Business Overview
10.2.5 Oncolytics Biotech Oncolytic Virus Therapy SWOT Analysis
10.2.6 Oncolytics Biotech Recent Developments
10.3 Viralytics
10.3.1 Viralytics Oncolytic Virus Therapy Basic Information
10.3.2 Viralytics Oncolytic Virus Therapy Product Overview
10.3.3 Viralytics Oncolytic Virus Therapy Product Market Performance
10.3.4 Viralytics Oncolytic Virus Therapy SWOT Analysis
10.3.5 Viralytics Business Overview
10.3.6 Viralytics Recent Developments
10.4 Transgene SA
10.4.1 Transgene SA Oncolytic Virus Therapy Basic Information
10.4.2 Transgene SA Oncolytic Virus Therapy Product Overview
10.4.3 Transgene SA Oncolytic Virus Therapy Product Market Performance
10.4.4 Transgene SA Business Overview
10.4.5 Transgene SA Recent Developments
10.5 Oncolys BioPharma
10.5.1 Oncolys BioPharma Oncolytic Virus Therapy Basic Information
10.5.2 Oncolys BioPharma Oncolytic Virus Therapy Product Overview
10.5.3 Oncolys BioPharma Oncolytic Virus Therapy Product Market Performance
10.5.4 Oncolys BioPharma Business Overview
10.5.5 Oncolys BioPharma Recent Developments
10.6 Targovax
10.6.1 Targovax Oncolytic Virus Therapy Basic Information
10.6.2 Targovax Oncolytic Virus Therapy Product Overview
10.6.3 Targovax Oncolytic Virus Therapy Product Market Performance
10.6.4 Targovax Business Overview
10.6.5 Targovax Recent Developments
10.7 PsiOxus Therapeutics
10.7.1 PsiOxus Therapeutics Oncolytic Virus Therapy Basic Information
10.7.2 PsiOxus Therapeutics Oncolytic Virus Therapy Product Overview
10.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Product Market Performance
10.7.4 PsiOxus Therapeutics Business Overview
10.7.5 PsiOxus Therapeutics Recent Developments
10.8 SillaJen Biotherapeutics
10.8.1 SillaJen Biotherapeutics Oncolytic Virus Therapy Basic Information
10.8.2 SillaJen Biotherapeutics Oncolytic Virus Therapy Product Overview
10.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Product Market Performance
10.8.4 SillaJen Biotherapeutics Business Overview
10.8.5 SillaJen Biotherapeutics Recent Developments
10.9 Sorrento Therapeutics
10.9.1 Sorrento Therapeutics Oncolytic Virus Therapy Basic Information
10.9.2 Sorrento Therapeutics Oncolytic Virus Therapy Product Overview
10.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Product Market Performance
10.9.4 Sorrento Therapeutics Business Overview
10.9.5 Sorrento Therapeutics Recent Developments
10.10 Lokon Pharma
10.10.1 Lokon Pharma Oncolytic Virus Therapy Basic Information
10.10.2 Lokon Pharma Oncolytic Virus Therapy Product Overview
10.10.3 Lokon Pharma Oncolytic Virus Therapy Product Market Performance
10.10.4 Lokon Pharma Business Overview
10.10.5 Lokon Pharma Recent Developments
10.11 Genelux Corporation
10.11.1 Genelux Corporation Oncolytic Virus Therapy Basic Information
10.11.2 Genelux Corporation Oncolytic Virus Therapy Product Overview
10.11.3 Genelux Corporation Oncolytic Virus Therapy Product Market Performance
10.11.4 Genelux Corporation Business Overview
10.11.5 Genelux Corporation Recent Developments
10.12 Vyriad
10.12.1 Vyriad Oncolytic Virus Therapy Basic Information
10.12.2 Vyriad Oncolytic Virus Therapy Product Overview
10.12.3 Vyriad Oncolytic Virus Therapy Product Market Performance
10.12.4 Vyriad Business Overview
10.12.5 Vyriad Recent Developments
10.13 TILT Biotherapeutics
10.13.1 TILT Biotherapeutics Oncolytic Virus Therapy Basic Information
10.13.2 TILT Biotherapeutics Oncolytic Virus Therapy Product Overview
10.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Product Market Performance
10.13.4 TILT Biotherapeutics Business Overview
10.13.5 TILT Biotherapeutics Recent Developments
10.14 Cold Genesys
10.14.1 Cold Genesys Oncolytic Virus Therapy Basic Information
10.14.2 Cold Genesys Oncolytic Virus Therapy Product Overview
10.14.3 Cold Genesys Oncolytic Virus Therapy Product Market Performance
10.14.4 Cold Genesys Business Overview
10.14.5 Cold Genesys Recent Developments
11 ONCOLYTIC VIRUS THERAPY MARKET FORECAST BY REGION
11.1 Global Oncolytic Virus Therapy Market Size Forecast
11.2 Global Oncolytic Virus Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oncolytic Virus Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Oncolytic Virus Therapy Market Size Forecast by Region
11.2.4 South America Oncolytic Virus Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Oncolytic Virus Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Oncolytic Virus Therapy Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Oncolytic Virus Therapy by Type (2025-2032)
12.1.2 Global Oncolytic Virus Therapy Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Oncolytic Virus Therapy by Type (2025-2032)
12.2 Global Oncolytic Virus Therapy Market Forecast by Application (2025-2032)
12.2.1 Global Oncolytic Virus Therapy Sales (K Units) Forecast by Application
12.2.2 Global Oncolytic Virus Therapy Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Oncolytic Virus Therapy
1.2 Key Market Segments
1.2.1 Oncolytic Virus Therapy Segment by Type
1.2.2 Oncolytic Virus Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONCOLYTIC VIRUS THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oncolytic Virus Therapy Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Oncolytic Virus Therapy Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONCOLYTIC VIRUS THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Oncolytic Virus Therapy Sales by Manufacturers (2019-2024)
3.2 Global Oncolytic Virus Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oncolytic Virus Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oncolytic Virus Therapy Sales Sites, Area Served, Product Type
3.6 Oncolytic Virus Therapy Market Competitive Situation and Trends
3.6.1 Oncolytic Virus Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oncolytic Virus Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ONCOLYTIC VIRUS THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Oncolytic Virus Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONCOLYTIC VIRUS THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ONCOLYTIC VIRUS THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncolytic Virus Therapy Sales Market Share by Type (2019-2024)
6.3 Global Oncolytic Virus Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Oncolytic Virus Therapy Price by Type (2019-2024)
7 ONCOLYTIC VIRUS THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncolytic Virus Therapy Market Sales by Application (2019-2024)
7.3 Global Oncolytic Virus Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Oncolytic Virus Therapy Sales Growth Rate by Application (2019-2024)
8 ONCOLYTIC VIRUS THERAPY MARKET CONSUMPTION BY REGION
8.1 Global Oncolytic Virus Therapy Sales by Region
8.1.1 Global Oncolytic Virus Therapy Sales by Region
8.1.2 Global Oncolytic Virus Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Oncolytic Virus Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oncolytic Virus Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oncolytic Virus Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oncolytic Virus Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oncolytic Virus Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 ONCOLYTIC VIRUS THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Oncolytic Virus Therapy by Region (2019-2024)
9.2 Global Oncolytic Virus Therapy Revenue Market Share by Region (2019-2024)
9.3 Global Oncolytic Virus Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Oncolytic Virus Therapy Production
9.4.1 North America Oncolytic Virus Therapy Production Growth Rate (2019-2024)
9.4.2 North America Oncolytic Virus Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Oncolytic Virus Therapy Production
9.5.1 Europe Oncolytic Virus Therapy Production Growth Rate (2019-2024)
9.5.2 Europe Oncolytic Virus Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Oncolytic Virus Therapy Production (2019-2024)
9.6.1 Japan Oncolytic Virus Therapy Production Growth Rate (2019-2024)
9.6.2 Japan Oncolytic Virus Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Oncolytic Virus Therapy Production (2019-2024)
9.7.1 China Oncolytic Virus Therapy Production Growth Rate (2019-2024)
9.7.2 China Oncolytic Virus Therapy Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Amgen
10.1.1 Amgen Oncolytic Virus Therapy Basic Information
10.1.2 Amgen Oncolytic Virus Therapy Product Overview
10.1.3 Amgen Oncolytic Virus Therapy Product Market Performance
10.1.4 Amgen Business Overview
10.1.5 Amgen Oncolytic Virus Therapy SWOT Analysis
10.1.6 Amgen Recent Developments
10.2 Oncolytics Biotech
10.2.1 Oncolytics Biotech Oncolytic Virus Therapy Basic Information
10.2.2 Oncolytics Biotech Oncolytic Virus Therapy Product Overview
10.2.3 Oncolytics Biotech Oncolytic Virus Therapy Product Market Performance
10.2.4 Oncolytics Biotech Business Overview
10.2.5 Oncolytics Biotech Oncolytic Virus Therapy SWOT Analysis
10.2.6 Oncolytics Biotech Recent Developments
10.3 Viralytics
10.3.1 Viralytics Oncolytic Virus Therapy Basic Information
10.3.2 Viralytics Oncolytic Virus Therapy Product Overview
10.3.3 Viralytics Oncolytic Virus Therapy Product Market Performance
10.3.4 Viralytics Oncolytic Virus Therapy SWOT Analysis
10.3.5 Viralytics Business Overview
10.3.6 Viralytics Recent Developments
10.4 Transgene SA
10.4.1 Transgene SA Oncolytic Virus Therapy Basic Information
10.4.2 Transgene SA Oncolytic Virus Therapy Product Overview
10.4.3 Transgene SA Oncolytic Virus Therapy Product Market Performance
10.4.4 Transgene SA Business Overview
10.4.5 Transgene SA Recent Developments
10.5 Oncolys BioPharma
10.5.1 Oncolys BioPharma Oncolytic Virus Therapy Basic Information
10.5.2 Oncolys BioPharma Oncolytic Virus Therapy Product Overview
10.5.3 Oncolys BioPharma Oncolytic Virus Therapy Product Market Performance
10.5.4 Oncolys BioPharma Business Overview
10.5.5 Oncolys BioPharma Recent Developments
10.6 Targovax
10.6.1 Targovax Oncolytic Virus Therapy Basic Information
10.6.2 Targovax Oncolytic Virus Therapy Product Overview
10.6.3 Targovax Oncolytic Virus Therapy Product Market Performance
10.6.4 Targovax Business Overview
10.6.5 Targovax Recent Developments
10.7 PsiOxus Therapeutics
10.7.1 PsiOxus Therapeutics Oncolytic Virus Therapy Basic Information
10.7.2 PsiOxus Therapeutics Oncolytic Virus Therapy Product Overview
10.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Product Market Performance
10.7.4 PsiOxus Therapeutics Business Overview
10.7.5 PsiOxus Therapeutics Recent Developments
10.8 SillaJen Biotherapeutics
10.8.1 SillaJen Biotherapeutics Oncolytic Virus Therapy Basic Information
10.8.2 SillaJen Biotherapeutics Oncolytic Virus Therapy Product Overview
10.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Product Market Performance
10.8.4 SillaJen Biotherapeutics Business Overview
10.8.5 SillaJen Biotherapeutics Recent Developments
10.9 Sorrento Therapeutics
10.9.1 Sorrento Therapeutics Oncolytic Virus Therapy Basic Information
10.9.2 Sorrento Therapeutics Oncolytic Virus Therapy Product Overview
10.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Product Market Performance
10.9.4 Sorrento Therapeutics Business Overview
10.9.5 Sorrento Therapeutics Recent Developments
10.10 Lokon Pharma
10.10.1 Lokon Pharma Oncolytic Virus Therapy Basic Information
10.10.2 Lokon Pharma Oncolytic Virus Therapy Product Overview
10.10.3 Lokon Pharma Oncolytic Virus Therapy Product Market Performance
10.10.4 Lokon Pharma Business Overview
10.10.5 Lokon Pharma Recent Developments
10.11 Genelux Corporation
10.11.1 Genelux Corporation Oncolytic Virus Therapy Basic Information
10.11.2 Genelux Corporation Oncolytic Virus Therapy Product Overview
10.11.3 Genelux Corporation Oncolytic Virus Therapy Product Market Performance
10.11.4 Genelux Corporation Business Overview
10.11.5 Genelux Corporation Recent Developments
10.12 Vyriad
10.12.1 Vyriad Oncolytic Virus Therapy Basic Information
10.12.2 Vyriad Oncolytic Virus Therapy Product Overview
10.12.3 Vyriad Oncolytic Virus Therapy Product Market Performance
10.12.4 Vyriad Business Overview
10.12.5 Vyriad Recent Developments
10.13 TILT Biotherapeutics
10.13.1 TILT Biotherapeutics Oncolytic Virus Therapy Basic Information
10.13.2 TILT Biotherapeutics Oncolytic Virus Therapy Product Overview
10.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Product Market Performance
10.13.4 TILT Biotherapeutics Business Overview
10.13.5 TILT Biotherapeutics Recent Developments
10.14 Cold Genesys
10.14.1 Cold Genesys Oncolytic Virus Therapy Basic Information
10.14.2 Cold Genesys Oncolytic Virus Therapy Product Overview
10.14.3 Cold Genesys Oncolytic Virus Therapy Product Market Performance
10.14.4 Cold Genesys Business Overview
10.14.5 Cold Genesys Recent Developments
11 ONCOLYTIC VIRUS THERAPY MARKET FORECAST BY REGION
11.1 Global Oncolytic Virus Therapy Market Size Forecast
11.2 Global Oncolytic Virus Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oncolytic Virus Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Oncolytic Virus Therapy Market Size Forecast by Region
11.2.4 South America Oncolytic Virus Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Oncolytic Virus Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Oncolytic Virus Therapy Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Oncolytic Virus Therapy by Type (2025-2032)
12.1.2 Global Oncolytic Virus Therapy Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Oncolytic Virus Therapy by Type (2025-2032)
12.2 Global Oncolytic Virus Therapy Market Forecast by Application (2025-2032)
12.2.1 Global Oncolytic Virus Therapy Sales (K Units) Forecast by Application
12.2.2 Global Oncolytic Virus Therapy Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Oncolytic Virus Therapy Market Size Comparison by Region (M USD)
Table 5. Global Oncolytic Virus Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Oncolytic Virus Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Oncolytic Virus Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Oncolytic Virus Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Therapy as of 2022)
Table 10. Global Market Oncolytic Virus Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Oncolytic Virus Therapy Sales Sites and Area Served
Table 12. Manufacturers Oncolytic Virus Therapy Product Type
Table 13. Global Oncolytic Virus Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Oncolytic Virus Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oncolytic Virus Therapy Market Challenges
Table 22. Global Oncolytic Virus Therapy Sales by Type (K Units)
Table 23. Global Oncolytic Virus Therapy Market Size by Type (M USD)
Table 24. Global Oncolytic Virus Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global Oncolytic Virus Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Oncolytic Virus Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Oncolytic Virus Therapy Market Size Share by Type (2019-2024)
Table 28. Global Oncolytic Virus Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Oncolytic Virus Therapy Sales (K Units) by Application
Table 30. Global Oncolytic Virus Therapy Market Size by Application
Table 31. Global Oncolytic Virus Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Oncolytic Virus Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Oncolytic Virus Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Oncolytic Virus Therapy Market Share by Application (2019-2024)
Table 35. Global Oncolytic Virus Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Oncolytic Virus Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Oncolytic Virus Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Oncolytic Virus Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Oncolytic Virus Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Oncolytic Virus Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Oncolytic Virus Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Oncolytic Virus Therapy Sales by Region (2019-2024) & (K Units)
Table 43. Global Oncolytic Virus Therapy Production (K Units) by Region (2019-2024)
Table 44. Global Oncolytic Virus Therapy Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Oncolytic Virus Therapy Revenue Market Share by Region (2019-2024)
Table 46. Global Oncolytic Virus Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Oncolytic Virus Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Oncolytic Virus Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Oncolytic Virus Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Oncolytic Virus Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Amgen Oncolytic Virus Therapy Basic Information
Table 52. Amgen Oncolytic Virus Therapy Product Overview
Table 53. Amgen Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Amgen Business Overview
Table 55. Amgen Oncolytic Virus Therapy SWOT Analysis
Table 56. Amgen Recent Developments
Table 57. Oncolytics Biotech Oncolytic Virus Therapy Basic Information
Table 58. Oncolytics Biotech Oncolytic Virus Therapy Product Overview
Table 59. Oncolytics Biotech Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Oncolytics Biotech Business Overview
Table 61. Oncolytics Biotech Oncolytic Virus Therapy SWOT Analysis
Table 62. Oncolytics Biotech Recent Developments
Table 63. Viralytics Oncolytic Virus Therapy Basic Information
Table 64. Viralytics Oncolytic Virus Therapy Product Overview
Table 65. Viralytics Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Viralytics Oncolytic Virus Therapy SWOT Analysis
Table 67. Viralytics Business Overview
Table 68. Viralytics Recent Developments
Table 69. Transgene SA Oncolytic Virus Therapy Basic Information
Table 70. Transgene SA Oncolytic Virus Therapy Product Overview
Table 71. Transgene SA Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Transgene SA Business Overview
Table 73. Transgene SA Recent Developments
Table 74. Oncolys BioPharma Oncolytic Virus Therapy Basic Information
Table 75. Oncolys BioPharma Oncolytic Virus Therapy Product Overview
Table 76. Oncolys BioPharma Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Oncolys BioPharma Business Overview
Table 78. Oncolys BioPharma Recent Developments
Table 79. Targovax Oncolytic Virus Therapy Basic Information
Table 80. Targovax Oncolytic Virus Therapy Product Overview
Table 81. Targovax Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Targovax Business Overview
Table 83. Targovax Recent Developments
Table 84. PsiOxus Therapeutics Oncolytic Virus Therapy Basic Information
Table 85. PsiOxus Therapeutics Oncolytic Virus Therapy Product Overview
Table 86. PsiOxus Therapeutics Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. PsiOxus Therapeutics Business Overview
Table 88. PsiOxus Therapeutics Recent Developments
Table 89. SillaJen Biotherapeutics Oncolytic Virus Therapy Basic Information
Table 90. SillaJen Biotherapeutics Oncolytic Virus Therapy Product Overview
Table 91. SillaJen Biotherapeutics Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. SillaJen Biotherapeutics Business Overview
Table 93. SillaJen Biotherapeutics Recent Developments
Table 94. Sorrento Therapeutics Oncolytic Virus Therapy Basic Information
Table 95. Sorrento Therapeutics Oncolytic Virus Therapy Product Overview
Table 96. Sorrento Therapeutics Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Sorrento Therapeutics Business Overview
Table 98. Sorrento Therapeutics Recent Developments
Table 99. Lokon Pharma Oncolytic Virus Therapy Basic Information
Table 100. Lokon Pharma Oncolytic Virus Therapy Product Overview
Table 101. Lokon Pharma Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Lokon Pharma Business Overview
Table 103. Lokon Pharma Recent Developments
Table 104. Genelux Corporation Oncolytic Virus Therapy Basic Information
Table 105. Genelux Corporation Oncolytic Virus Therapy Product Overview
Table 106. Genelux Corporation Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Genelux Corporation Business Overview
Table 108. Genelux Corporation Recent Developments
Table 109. Vyriad Oncolytic Virus Therapy Basic Information
Table 110. Vyriad Oncolytic Virus Therapy Product Overview
Table 111. Vyriad Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Vyriad Business Overview
Table 113. Vyriad Recent Developments
Table 114. TILT Biotherapeutics Oncolytic Virus Therapy Basic Information
Table 115. TILT Biotherapeutics Oncolytic Virus Therapy Product Overview
Table 116. TILT Biotherapeutics Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. TILT Biotherapeutics Business Overview
Table 118. TILT Biotherapeutics Recent Developments
Table 119. Cold Genesys Oncolytic Virus Therapy Basic Information
Table 120. Cold Genesys Oncolytic Virus Therapy Product Overview
Table 121. Cold Genesys Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Cold Genesys Business Overview
Table 123. Cold Genesys Recent Developments
Table 124. Global Oncolytic Virus Therapy Sales Forecast by Region (2025-2032) & (K Units)
Table 125. Global Oncolytic Virus Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 126. North America Oncolytic Virus Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 127. North America Oncolytic Virus Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 128. Europe Oncolytic Virus Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 129. Europe Oncolytic Virus Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 130. Asia Pacific Oncolytic Virus Therapy Sales Forecast by Region (2025-2032) & (K Units)
Table 131. Asia Pacific Oncolytic Virus Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 132. South America Oncolytic Virus Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 133. South America Oncolytic Virus Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 134. Middle East and Africa Oncolytic Virus Therapy Consumption Forecast by Country (2025-2032) & (Units)
Table 135. Middle East and Africa Oncolytic Virus Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 136. Global Oncolytic Virus Therapy Sales Forecast by Type (2025-2032) & (K Units)
Table 137. Global Oncolytic Virus Therapy Market Size Forecast by Type (2025-2032) & (M USD)
Table 138. Global Oncolytic Virus Therapy Price Forecast by Type (2025-2032) & (USD/Unit)
Table 139. Global Oncolytic Virus Therapy Sales (K Units) Forecast by Application (2025-2032)
Table 140. Global Oncolytic Virus Therapy Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Oncolytic Virus Therapy Market Size Comparison by Region (M USD)
Table 5. Global Oncolytic Virus Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Oncolytic Virus Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Oncolytic Virus Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Oncolytic Virus Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Therapy as of 2022)
Table 10. Global Market Oncolytic Virus Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Oncolytic Virus Therapy Sales Sites and Area Served
Table 12. Manufacturers Oncolytic Virus Therapy Product Type
Table 13. Global Oncolytic Virus Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Oncolytic Virus Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oncolytic Virus Therapy Market Challenges
Table 22. Global Oncolytic Virus Therapy Sales by Type (K Units)
Table 23. Global Oncolytic Virus Therapy Market Size by Type (M USD)
Table 24. Global Oncolytic Virus Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global Oncolytic Virus Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Oncolytic Virus Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Oncolytic Virus Therapy Market Size Share by Type (2019-2024)
Table 28. Global Oncolytic Virus Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Oncolytic Virus Therapy Sales (K Units) by Application
Table 30. Global Oncolytic Virus Therapy Market Size by Application
Table 31. Global Oncolytic Virus Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Oncolytic Virus Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Oncolytic Virus Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Oncolytic Virus Therapy Market Share by Application (2019-2024)
Table 35. Global Oncolytic Virus Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Oncolytic Virus Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Oncolytic Virus Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Oncolytic Virus Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Oncolytic Virus Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Oncolytic Virus Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Oncolytic Virus Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Oncolytic Virus Therapy Sales by Region (2019-2024) & (K Units)
Table 43. Global Oncolytic Virus Therapy Production (K Units) by Region (2019-2024)
Table 44. Global Oncolytic Virus Therapy Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Oncolytic Virus Therapy Revenue Market Share by Region (2019-2024)
Table 46. Global Oncolytic Virus Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Oncolytic Virus Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Oncolytic Virus Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Oncolytic Virus Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Oncolytic Virus Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Amgen Oncolytic Virus Therapy Basic Information
Table 52. Amgen Oncolytic Virus Therapy Product Overview
Table 53. Amgen Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Amgen Business Overview
Table 55. Amgen Oncolytic Virus Therapy SWOT Analysis
Table 56. Amgen Recent Developments
Table 57. Oncolytics Biotech Oncolytic Virus Therapy Basic Information
Table 58. Oncolytics Biotech Oncolytic Virus Therapy Product Overview
Table 59. Oncolytics Biotech Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Oncolytics Biotech Business Overview
Table 61. Oncolytics Biotech Oncolytic Virus Therapy SWOT Analysis
Table 62. Oncolytics Biotech Recent Developments
Table 63. Viralytics Oncolytic Virus Therapy Basic Information
Table 64. Viralytics Oncolytic Virus Therapy Product Overview
Table 65. Viralytics Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Viralytics Oncolytic Virus Therapy SWOT Analysis
Table 67. Viralytics Business Overview
Table 68. Viralytics Recent Developments
Table 69. Transgene SA Oncolytic Virus Therapy Basic Information
Table 70. Transgene SA Oncolytic Virus Therapy Product Overview
Table 71. Transgene SA Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Transgene SA Business Overview
Table 73. Transgene SA Recent Developments
Table 74. Oncolys BioPharma Oncolytic Virus Therapy Basic Information
Table 75. Oncolys BioPharma Oncolytic Virus Therapy Product Overview
Table 76. Oncolys BioPharma Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Oncolys BioPharma Business Overview
Table 78. Oncolys BioPharma Recent Developments
Table 79. Targovax Oncolytic Virus Therapy Basic Information
Table 80. Targovax Oncolytic Virus Therapy Product Overview
Table 81. Targovax Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Targovax Business Overview
Table 83. Targovax Recent Developments
Table 84. PsiOxus Therapeutics Oncolytic Virus Therapy Basic Information
Table 85. PsiOxus Therapeutics Oncolytic Virus Therapy Product Overview
Table 86. PsiOxus Therapeutics Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. PsiOxus Therapeutics Business Overview
Table 88. PsiOxus Therapeutics Recent Developments
Table 89. SillaJen Biotherapeutics Oncolytic Virus Therapy Basic Information
Table 90. SillaJen Biotherapeutics Oncolytic Virus Therapy Product Overview
Table 91. SillaJen Biotherapeutics Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. SillaJen Biotherapeutics Business Overview
Table 93. SillaJen Biotherapeutics Recent Developments
Table 94. Sorrento Therapeutics Oncolytic Virus Therapy Basic Information
Table 95. Sorrento Therapeutics Oncolytic Virus Therapy Product Overview
Table 96. Sorrento Therapeutics Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Sorrento Therapeutics Business Overview
Table 98. Sorrento Therapeutics Recent Developments
Table 99. Lokon Pharma Oncolytic Virus Therapy Basic Information
Table 100. Lokon Pharma Oncolytic Virus Therapy Product Overview
Table 101. Lokon Pharma Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Lokon Pharma Business Overview
Table 103. Lokon Pharma Recent Developments
Table 104. Genelux Corporation Oncolytic Virus Therapy Basic Information
Table 105. Genelux Corporation Oncolytic Virus Therapy Product Overview
Table 106. Genelux Corporation Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Genelux Corporation Business Overview
Table 108. Genelux Corporation Recent Developments
Table 109. Vyriad Oncolytic Virus Therapy Basic Information
Table 110. Vyriad Oncolytic Virus Therapy Product Overview
Table 111. Vyriad Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Vyriad Business Overview
Table 113. Vyriad Recent Developments
Table 114. TILT Biotherapeutics Oncolytic Virus Therapy Basic Information
Table 115. TILT Biotherapeutics Oncolytic Virus Therapy Product Overview
Table 116. TILT Biotherapeutics Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. TILT Biotherapeutics Business Overview
Table 118. TILT Biotherapeutics Recent Developments
Table 119. Cold Genesys Oncolytic Virus Therapy Basic Information
Table 120. Cold Genesys Oncolytic Virus Therapy Product Overview
Table 121. Cold Genesys Oncolytic Virus Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Cold Genesys Business Overview
Table 123. Cold Genesys Recent Developments
Table 124. Global Oncolytic Virus Therapy Sales Forecast by Region (2025-2032) & (K Units)
Table 125. Global Oncolytic Virus Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 126. North America Oncolytic Virus Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 127. North America Oncolytic Virus Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 128. Europe Oncolytic Virus Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 129. Europe Oncolytic Virus Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 130. Asia Pacific Oncolytic Virus Therapy Sales Forecast by Region (2025-2032) & (K Units)
Table 131. Asia Pacific Oncolytic Virus Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 132. South America Oncolytic Virus Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 133. South America Oncolytic Virus Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 134. Middle East and Africa Oncolytic Virus Therapy Consumption Forecast by Country (2025-2032) & (Units)
Table 135. Middle East and Africa Oncolytic Virus Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 136. Global Oncolytic Virus Therapy Sales Forecast by Type (2025-2032) & (K Units)
Table 137. Global Oncolytic Virus Therapy Market Size Forecast by Type (2025-2032) & (M USD)
Table 138. Global Oncolytic Virus Therapy Price Forecast by Type (2025-2032) & (USD/Unit)
Table 139. Global Oncolytic Virus Therapy Sales (K Units) Forecast by Application (2025-2032)
Table 140. Global Oncolytic Virus Therapy Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Oncolytic Virus Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oncolytic Virus Therapy Market Size (M USD), 2019-2032
Figure 5. Global Oncolytic Virus Therapy Market Size (M USD) (2019-2032)
Figure 6. Global Oncolytic Virus Therapy Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oncolytic Virus Therapy Market Size by Country (M USD)
Figure 11. Oncolytic Virus Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Oncolytic Virus Therapy Revenue Share by Manufacturers in 2023
Figure 13. Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Oncolytic Virus Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Oncolytic Virus Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Oncolytic Virus Therapy Market Share by Type
Figure 18. Sales Market Share of Oncolytic Virus Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Oncolytic Virus Therapy by Type in 2023
Figure 20. Market Size Share of Oncolytic Virus Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Oncolytic Virus Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Oncolytic Virus Therapy Market Share by Application
Figure 24. Global Oncolytic Virus Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Oncolytic Virus Therapy Sales Market Share by Application in 2023
Figure 26. Global Oncolytic Virus Therapy Market Share by Application (2019-2024)
Figure 27. Global Oncolytic Virus Therapy Market Share by Application in 2023
Figure 28. Global Oncolytic Virus Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Oncolytic Virus Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Oncolytic Virus Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Oncolytic Virus Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Oncolytic Virus Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Oncolytic Virus Therapy Sales Market Share by Country in 2023
Figure 37. Germany Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Oncolytic Virus Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Oncolytic Virus Therapy Sales Market Share by Region in 2023
Figure 44. China Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Oncolytic Virus Therapy Sales and Growth Rate (K Units)
Figure 50. South America Oncolytic Virus Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Oncolytic Virus Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Oncolytic Virus Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Oncolytic Virus Therapy Production Market Share by Region (2019-2024)
Figure 62. North America Oncolytic Virus Therapy Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Oncolytic Virus Therapy Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Oncolytic Virus Therapy Production (K Units) Growth Rate (2019-2024)
Figure 65. China Oncolytic Virus Therapy Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Oncolytic Virus Therapy Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Oncolytic Virus Therapy Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Oncolytic Virus Therapy Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Oncolytic Virus Therapy Market Share Forecast by Type (2025-2032)
Figure 70. Global Oncolytic Virus Therapy Sales Forecast by Application (2025-2032)
Figure 71. Global Oncolytic Virus Therapy Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Oncolytic Virus Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oncolytic Virus Therapy Market Size (M USD), 2019-2032
Figure 5. Global Oncolytic Virus Therapy Market Size (M USD) (2019-2032)
Figure 6. Global Oncolytic Virus Therapy Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oncolytic Virus Therapy Market Size by Country (M USD)
Figure 11. Oncolytic Virus Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Oncolytic Virus Therapy Revenue Share by Manufacturers in 2023
Figure 13. Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Oncolytic Virus Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Oncolytic Virus Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Oncolytic Virus Therapy Market Share by Type
Figure 18. Sales Market Share of Oncolytic Virus Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Oncolytic Virus Therapy by Type in 2023
Figure 20. Market Size Share of Oncolytic Virus Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Oncolytic Virus Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Oncolytic Virus Therapy Market Share by Application
Figure 24. Global Oncolytic Virus Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Oncolytic Virus Therapy Sales Market Share by Application in 2023
Figure 26. Global Oncolytic Virus Therapy Market Share by Application (2019-2024)
Figure 27. Global Oncolytic Virus Therapy Market Share by Application in 2023
Figure 28. Global Oncolytic Virus Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Oncolytic Virus Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Oncolytic Virus Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Oncolytic Virus Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Oncolytic Virus Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Oncolytic Virus Therapy Sales Market Share by Country in 2023
Figure 37. Germany Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Oncolytic Virus Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Oncolytic Virus Therapy Sales Market Share by Region in 2023
Figure 44. China Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Oncolytic Virus Therapy Sales and Growth Rate (K Units)
Figure 50. South America Oncolytic Virus Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Oncolytic Virus Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Oncolytic Virus Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Oncolytic Virus Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Oncolytic Virus Therapy Production Market Share by Region (2019-2024)
Figure 62. North America Oncolytic Virus Therapy Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Oncolytic Virus Therapy Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Oncolytic Virus Therapy Production (K Units) Growth Rate (2019-2024)
Figure 65. China Oncolytic Virus Therapy Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Oncolytic Virus Therapy Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Oncolytic Virus Therapy Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Oncolytic Virus Therapy Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Oncolytic Virus Therapy Market Share Forecast by Type (2025-2032)
Figure 70. Global Oncolytic Virus Therapy Sales Forecast by Application (2025-2032)
Figure 71. Global Oncolytic Virus Therapy Market Share Forecast by Application (2025-2032)
